| Metric | FY 2022 | Prior Q | FY 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $143M | — | — | — | — |
| Op. Income | $95M | — | — | — | — |
| Gross Margin | 75.7% | — | — | — | — |
| Net Margin | 47.6% | — | — | — | — |
| EPS (Diluted) | $1.16 | — | — | — | — |
| Free Cash Flow | -$31M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $143M |
| Cost of Revenue | $35M |
| GROSS PROFIT | $108M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $13M |
| SG&A Expenses | $13M |
| Other Expenses | $0 |
| Operating Expenses | $13M |
| Cost & Expenses | $48M |
| OPERATING INCOME | $95M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$27M |
| INCOME BEFORE TAX | $68M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $68M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $68M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $68M |
| D&A | $18M |
| EBIT | $71M |
| EBITDA | $89M |
| EPS | $5 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $143M |
| Cost of Revenue | $35M |
| GROSS PROFIT | $108M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $13M |
| SG&A Expenses | $13M |
| Other Expenses | $0 |
| Operating Expenses | $13M |
| Cost & Expenses | $48M |
| OPERATING INCOME | $95M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$27M |
| INCOME BEFORE TAX | $68M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $68M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $68M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $68M |
| D&A | $18M |
| EBIT | $71M |
| EBITDA | $89M |
| EPS | $5 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $68M |
| Depreciation & Amortization | $18M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$13M |
| Change in Working Capital | -$9M |
| OPERATING CASH FLOW | $65M |
| Capital Expenditure | -$96M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$96M |
| Net Debt Issuance | $30M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$908.0K |
| NET CASH FROM FINANCING | $29M |
| FREE CASH FLOW | -$31M |
| Net Change in Cash | -$2M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $739.0K |
| Short-Term Investments | $0 |
| Net Receivables | $22M |
| Inventory | $0 |
| Other Current Assets | $6M |
| TOTAL CURRENT ASSETS | $29M |
| PP&E (Net) | $234M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $2M |
| Tax Assets | $0 |
| Other Non-Current Assets | $1M |
| TOTAL NON-CURRENT ASSETS | $238M |
| TOTAL ASSETS | $267M |
| Account Payables | $41M |
| Short-Term Debt | $93.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $6M |
| TOTAL CURRENT LIABILITIES | $57M |
| Long-Term Debt | $58M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $1M |
| TOTAL NON-CURRENT LIABILITIES | $60M |
| TOTAL LIABILITIES | $117M |
| Common Stock | $150M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $150M |
| Minority Interest | $0 |
| TOTAL EQUITY | $150M |
| TOTAL LIABILITIES & EQUITY | $267M |
| Total Debt | $59M |
| Net Debt | $58M |
